DeCODE Launches DeCODE BreastCancer(TM), A Genetic Test To Screen For Risk Of The Com
 

deCODE genetics (Nasdaq: DCGN) announced the launch of deCODE BreastCancer(TM), a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can speak with her physician about a genetic test to better understand her lifetime risk of developing the common forms of the disease.

More...